Valuation: Ecomat Inc.

Market Cap 4L 4L 3L 3L 6L 4.04Cr 6L 40.61L 15.89L 1.98Cr 15.73L 15.39L 6.84Cr P/E 2022
-14.8x
P/E 2023 -25x
Enterprise Value 8L 7L 7L 6L 11.76L 8.05Cr 11.93L 80.88L 31.66L 3.94Cr 31.33L 30.66L 14Cr EV / Sales 2022
-
EV / Sales 2023 65,89,581x
Free-Float
8.59%
Yield 2022 *
-
Yield 2023 -
Manager TitleAgeSince
Chief Executive Officer 43 30/09/2022
Director TitleAgeSince
Chairman 43 30/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-57.14%-46.43% - - 714
+2.27%+0.90%+165.31% - 113.05Cr
+0.74%-1.73%-21.98%+149.16% 72Cr
+1.60%-1.01%-45.46%+204.08% 51Cr
0.00%+0.20%-0.79% - 8.08Cr
Average -10.51%-0.51%+24.27%+176.62% 61.02Cr
Weighted average by Cap. +1.60%-0.31%+60.58%+171.89%

Financials

2022 2023
Net sales - 0.42 0.37 0.35 0.32 0.6 40.95 0.61 4.11 1.61 20.04 1.59 1.56 69.22
Net income -1L -1L -93.22T -85.66T -2L -1.11Cr -2L -11.11L -4L -54.11L -4L -4L -1.87Cr -89.92T -78.79T -73.14T -67.21T -1L -86.77L -1L -9L -3L -42.46L -3L -3L -1.47Cr
Net Debt 2L 2L 2L 1L 3L 1.84Cr 3L 18.52L 7L 90.23L 7L 7L 3.12Cr 4L 4L 3L 3L 6L 4.01Cr 6L 40.27L 15.76L 1.96Cr 15.6L 15.27L 6.78Cr
Logo Ecomat Inc.
Ecomax, Inc. is engaged in selling and distributing Rocitin NMN products to customers in the Territory. Rocitin NMN is a nutritional supplement manufactured by Pharmazeutische Fabrik Evers GmbH & Co. KG, a German company. Each bottle contains 60 capsules, 10080 mg of NMN. NMN, as β-Nicotinamide Mononucleotide exists in some fruits, vegetables, and poultry. It is a molecule naturally occurring in all life forms and can be transformed into a significant coenzyme NAD+ within cells, which is important to human metabolism. Its research, including Nicotinamide mononucleotide (NMN) as an anti-aging health product has shown that NAD+ levels in the body will decrease with age, and that exogenous supplementation of NMN enhances NAD+ levels and thus the function of human cells. In addition, NMN also helps to repair broken DNA, regulate the stability of DNA and cell death, and improve neurodegenerative and metabolic conditions.
Employees
-